The U.S. Food and Drug Administration granted accelerated approval on Monday for the PD-1 inhibitor dostarlimab (Jemperli) to treat certain operable.

Long COVID linked to altered airway bacteria profiles, with reduced diversity correlating to symptom severity six months post-infection.











The U.S. Food and Drug Administration granted accelerated approval on Monday for the PD-1 inhibitor dostarlimab (Jemperli) to…

Limited mRNA flu shot supply is causing challenges for adults over 50 seeking Moderna's mFlusiva, as distribution has…

Risankizumab crohn's treatment shows 55% remission at 12 weeks vs 29.6% placebo, improving outcomes for Crohn's disease patients.

FIT test may miss more colorectal cancers in women than men using standard thresholds, per a study of…

Embryo transfer shows higher effectiveness than IUI for IBD fertility treatment, with 75% pregnancy success in a study…

Long COVID linked to altered airway bacteria profiles, with reduced diversity correlating to symptom severity six months post-infection.

Avacopan showed strong efficacy in an Italian registry study treating ANCA-associated vasculitis, with all but one of 32…

New treatments emerge for chronic hives, including advances in interleukin receptor blockade.

MedPage Today journalists have collected a series of honors that underline the outlet’s role in delivering reliable medical…

Most teen colorectal cancer cases are identified at later stages, with 80% presenting as stage III or IV,…